treatment options for patients with tp53-mutated aml
Published 1 year ago • 1K plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
2:23
improving treatment for patients with tp53-mutated myeloid malignancies
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:39
treatment approaches for patients with tp53m aml ineligible for high intensity chemotherapy
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
8:14
progress in the treatment of tp53 mutated aml
-
0:58
options available to patients with tp53-mutated mds beyond stem cell transplantation
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
14:43
current research into post-allosct maintenance therapy in aml
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
16:56
p53 mutations in cancer
-
2:57
novel targeted therapies for the treatment of bpdcn
-
1:57
the benefit of allogeneic transplantation in patients with tp53-mutated aml
-
2:24
the challenges of treating tp53-mutated aml and mds
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
1:27
tp53-aberrant mcl: challenges and treatment approaches
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
3:00
apr-246 in tp53 mutated mds and aml
-
1:04
continuous treatment with flt3 inhibitors for patients with flt3-mutated aml undergoing allosct
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:19
new treatments for aml